Drug Decriminalization in Portugal: Challenges and Limitations (Book, 2010) [WorldCat.org]
skip to content
Drug Decriminalization in Portugal: Challenges and Limitations
Checking...

Drug Decriminalization in Portugal: Challenges and Limitations

Author: Office of National Drug Control Policy Old Executive Office Building Washington DC 20500
Publisher: United States 2010
Edition/Format: Book Book : English
Summary:
In July 2001, Portugal decriminalized the personal use and possession of all illicit drugs. Following passage of Law 30/2000, Portugal refers cases of consumption, purchase, or possession of up to a 10 days' supply of an illicit drug to an administrative panel, which makes recommendations for treatment, fines, warnings, or other penalties. Trafficking and cultivation of illicit substances, as well as possession of  Read more...
Rating:

(not yet rated) 0 with reviews - Be the first.

Find a copy online

Links to this item

Find a copy in the library

We were unable to get information about libraries that hold this item.

Details

Document Type: Book
All Authors / Contributors: Office of National Drug Control Policy Old Executive Office Building Washington DC 20500
Language Note: English
Unique Identifier: 4777970687
Notes: ANNOTATION: This fact sheet reviews research that has examined the impact of drug decriminalization in Portugal.
Sale: NCJRS Photocopy Services, Box 6000, Rockville, MD 20849-6000
Sale: Office of National Drug Control Policy, Old Executive Office Building, Washington, DC 20500
Awards:
Description: 2 p

Abstract:

In July 2001, Portugal decriminalized the personal use and possession of all illicit drugs. Following passage of Law 30/2000, Portugal refers cases of consumption, purchase, or possession of up to a 10 days' supply of an illicit drug to an administrative panel, which makes recommendations for treatment, fines, warnings, or other penalties. Trafficking and cultivation of illicit substances, as well as possession of quantities that exceed a 10 days' supply, remain criminal offenses. Although Portugal's decriminalized drug policy has been cited as proof that softening drug laws does not increase illicit drug use or the consequences of drug use, this contention is based primarily on the findings published in a 2009 Cato Institute report. This report, however does not discuss the statistical significance of the data shifts that it highlights, sometimes focusing on prevalence-rate changes as small as 0.8 percent. In addition, the report attributes favorable trends to drug decriminalization without acknowledging the influence of other factors, such as the decline in drug-related deaths that preceded decriminalization. Also, evidence of possible adverse effects of drug decriminalization are sometimes ignored, de-emphasized, or not given equal weight with other findings. One such finding is the increase in drug-related deaths in Portugal between 2004 and 2006. Other limitations in the methodology and interpretation of data are also noted for the Cato Institute's study. Additional studies of the impact of Portugal's drug decriminalization have yielded evidence that is more contradictory than the Cato study; for example, statistics compiled by the European Monitoring Center for Drugs and Drug Addiction indicate that between 2001 and 2007, lifetime prevalence rates for cannabis, cocaine, amphetamines, ecstasy, and LSD have increased for the Portuguese general population (ages 15-64) and for the 15-34 age group. 9 notes

Reviews

User-contributed reviews
Retrieving GoodReads reviews...
Retrieving DOGObooks reviews...

Tags

Be the first.
Confirm this request

You may have already requested this item. Please select Ok if you would like to proceed with this request anyway.

Close Window

Please sign in to WorldCat 

Don't have an account? You can easily create a free account.